Tema Obesity & Cardiometabolic ETF (HRTS)
- Previous Close
30.90 - Open
30.70 - Bid --
- Ask --
- Day's Range
30.70 - 30.95 - 52 Week Range
26.26 - 35.58 - Volume
16,643 - Avg. Volume
26,831 - Net Assets 59.53M
- NAV 30.86
- PE Ratio (TTM) --
- Yield --
- YTD Daily Total Return 0.95%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.75%
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Tema Global Limited
Fund Family
Health
Fund Category
59.53M
Net Assets
2023-11-20
Inception Date
Performance Overview: HRTS
Trailing returns as of 4/26/2024. Category is Health.
People Also Watch
Holdings: HRTS
Top 10 Holdings (38.28% of Total Assets)
Sector Weightings
Recent News: HRTS
Research Reports: HRTS
LESL: Raising target price to $7.00
LESLIE'S INC has an Investment Rating of HOLD; a target price of $7.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetAnalyst Report: Invitation Homes Inc.
Invitation Homes owns a portfolio of nearly 83,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $300,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.
RatingPrice TargetDaily – Vickers Top Insider Picks for 12/18/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Analyst Report: Kenvue Inc
Kenvue Technologies Inc., formerly part of Johnson & Johnson, is a pure-play consumer health company. The company has three segments: Self Care, Skin Health & Beauty, and Essential Health. Major brands include Tylenol, Nicorette, Zyrtec, Neutrogena, Aveeno, Listerine, and Band-Aid. The company has 22,200 employees. KVUE shares are a component of the S&P 500.
RatingPrice Target